logo
Plus   Neg
Share
Email

Myriad : EndoPredict Predicts Response To Neoadjuvant Chemotherapy And Endocrine Therapy

Myriad Genetics Inc. (MYGN) said a prospective study demonstrated that the EndoPredict test predicts which patients with ER+, HER2- early-stage breast cancer will benefit from neoadjuvant therapy.

Peter Dubsky, M.D., lead author, speaking on behalf of the Austrian Breast and Colorectal Cancer Study Group said, "Based on these findings and prior studies, we are confident the EndoPredict test can add valuable information to aid in personalized treatment selection in neoadjuvant therapy and provides an important basis for future design of neoadjuvant clinical trials."

The primary objective of the prospective study was to test the predictive value of the EndoPredict test regarding tumor response after neoadjuvant chemotherapy (NaCT) or neoadjuvant endocrine therapy (NET) within the ABCSG-34 trial.

EndoPredict is a second-generation, 12-gene molecular prognostic test for patients diagnosed with breast cancer. The test provides vital information that helps clinicians devise personalized treatment plans for their patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tailored Brands Inc., which owns menswear brands Men's Wearhouse and Jos. A. Bank, has filed for bankruptcy protection, severely hit by sluggish demand amid the coronavirus woes. The company filed for chapter 11 protection in the U.S. Bankruptcy Court for the Southern District of Texas to implement financial restructuring plan. Shares of HSBC Holdings Plc (HSBC, HSBA.L) were down in London and Hong Kong trading after the Asia-focused British lender reported Monday sharply lower profit in its second quarter, hurt by higher expected credit losses, weak revenues as well as the absence of prior year gain. For fiscal 2020, the company projects expected credit losses or ECL charge in the range of $8 billion to $13 billion. Microsoft said Sunday that it is prepared to continue discussions to explore a purchase of TikTok in the United States. Other American investors could participate in the potential acquisition on a minority basis.
Follow RTT